AASLD: Oral HCV Combo Yields Rapid Response (CME/CE)
SAN FRANCISCO (MedPage Today) — A combination of two investigational antiviral drugs with different mechanisms of action against hepatitis C virus yielded quick and persistent responses in previous nonresponders without the use of pegylated interferon, a researcher said here.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com